DYNAGEN INC
10QSB, EX-27.1, 2000-08-14
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: DYNAGEN INC, 10QSB, EX-3.3, 2000-08-14
Next: OMNI NUTRACEUTICALS, 10-Q, 2000-08-14



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S FINANCIAL STATEMENTS FOR THE PERIOD ENDED JUNE 30, 2000 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-START>                                 JAN-01-2000
<PERIOD-END>                                   JUN-30-2000
<CASH>                                             339,373
<SECURITIES>                                             0
<RECEIVABLES>                                    6,338,673
<ALLOWANCES>                                       162,371
<INVENTORY>                                      8,953,070
<CURRENT-ASSETS>                                16,568,025
<PP&E>                                           5,381,856
<DEPRECIATION>                                   1,573,570
<TOTAL-ASSETS>                                  23,254,893
<CURRENT-LIABILITIES>                           16,343,555
<BONDS>                                          4,970,785
                                    0
                                            534
<COMMON>                                           742,515
<OTHER-SE>                                       1,197,504
<TOTAL-LIABILITY-AND-EQUITY>                    23,254,893
<SALES>                                         16,101,009
<TOTAL-REVENUES>                                16,101,009
<CGS>                                           11,651,564
<TOTAL-COSTS>                                    5,828,411
<OTHER-EXPENSES>                                  (772,677)
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                 972,133
<INCOME-PRETAX>                                 (1,578,422)
<INCOME-TAX>                                             0
<INCOME-CONTINUING>                             (1,578,422)
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                    (1,578,422)
<EPS-BASIC>                                          (0.03)
<EPS-DILUTED>                                        (0.03)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission